2016 Perinatal Hepatitis B Summit Announced
June 22, 1016
The DSHS Immunization Branch will be hosting the 2016 Texas Perinatal Hepatitis B Summit from July 19-20, 2016, in Austin, Texas. The Summit aims to bring together national and state experts on hepatitis B to share, discuss, and recommend strategies to improve immunization rates.
Learn More about the 2016 Perinatal Hepatitis B Summit
2016-2017 Texas Minimum State Vaccine Requirements for Students in Grades K-12
June 15, 2015
Sections 97.61-97.72 of the Texas Administrative Code are currently under revision. As a result, the 2016-2017 Texas Minimum State Vaccine Requirements for students in grades K-12 are not yet finalized. No new vaccine requirements have been proposed. However, please note that proposed changes to the meningococcal requirement for students entering grades 7-12 will require students in these grades to show proof of one dose of quadrivalent meningococcal conjugate vaccine (MCV4 or MenACWY) on or after the student’s 11th birthday. Additionally, the graded implementation of the hepatitis A requirement will extend to grades K-7, as currently prescribed in the 25 TAC §97.63. For additional information, please contact the Immunization Branch at (800) 252-9152.
HPV Strategic Plan
June 13, 2015
Senate Bill 200, 84th Legislature, Regular Session, 2015, charged the Health and Human Services Commission with developing a strategic plan to significantly reduce morbidity and mortality from human papillomavirus (HPV) associated cancer.
An outline of the
HPV Strategic Plan (PDF) was presented June 3, 2016.
Flu Vaccination Information Required on Public School Websites
February 8, 2016
In 2007, the Texas Legislature passed House Bill No. 1059, also known as the Emily Lastinger Act, which requires all public school districts to post immunization information prominently on the school district’s website, if the district has one.
Read more in the
Influenza Letter to Schools, February 2016 (PDF).
Pentacel® Vaccine Delay
December 3, 2015
The Texas Vaccines for Children (TVFC) Program was notified on November 30, 2015, by the Centers for Disease Control and Prevention regarding a temporary manufacturing delay of Sanofi Pastuer's Pentacel® vaccine (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate Vaccine). The vaccine delay will result in immediate vaccine allocation of this project to all VFC programs nationwide. The vaccine delay is anticipated to last through the summer of 2016.
In order to ensure that all TVFC providers have access to this vaccine over the next few months, TVFC provider Maximum Stock Levels (MSLs) for Pentacel® will be reduced immediately. However, further vaccine allocation reductions could be implemented based on manufacture and CDC guidance.
Options to reduce the use of Pentacel® include the use of single vaccines for some populations and the use of alternative combination vaccines. Providers should continue to follow the recommended immunization schedule and ensure that patients receive all recommended doses of DTaP, Hib, and polio vaccines.
For additional information, please see the following documents: